The Minerva Foundation's Medix Prize for 2022 awarded to a research group from the University of Helsinki. The research group produced new data on the modes of action of antidepressants.
Patients suffering from depression benefit from serotonin-increasing medications. This finding has resulted in a conclusion, commonly accepted for decades, that the primary cause of depression is a depletion in serotonin.
